Production (Stage)
Zimmer Biomet Holdings, Inc.
ZBH
$92.64
$0.971.06%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.30% | 3.84% | 4.34% | 4.58% | 4.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.30% | 3.84% | 4.34% | 4.58% | 4.85% |
| Cost of Revenue | 6.27% | 5.05% | 3.00% | 3.93% | 3.30% |
| Gross Profit | 2.15% | 3.37% | 4.88% | 4.83% | 5.47% |
| SG&A Expenses | 2.93% | 2.96% | 3.18% | 2.40% | 3.31% |
| Depreciation & Amortization | 5.37% | 5.41% | 5.67% | 7.74% | 7.71% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.84% | 3.34% | 2.71% | 3.07% | 3.62% |
| Operating Income | 1.19% | 5.82% | 11.00% | 10.77% | 9.94% |
| Income Before Tax | 5.54% | -2.86% | 45.79% | 53.25% | 69.00% |
| Income Tax Expenses | 346.05% | 211.37% | -122.64% | -85.86% | -78.03% |
| Earnings from Continuing Operations | -5.18% | -11.68% | 128.30% | 97.14% | 114.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -38.46% | -45.45% | -55.56% | -55.56% | -30.00% |
| Net Income | -5.24% | -11.74% | 128.44% | 97.21% | 114.34% |
| EBIT | 1.19% | 5.82% | 11.00% | 10.77% | 9.94% |
| EBITDA | 2.89% | 5.38% | 8.12% | 7.99% | 7.44% |
| EPS Basic | -2.38% | -9.28% | 131.89% | 99.18% | 116.20% |
| Normalized Basic EPS | 3.36% | 8.84% | 27.32% | 25.00% | 22.41% |
| EPS Diluted | -2.22% | -9.05% | 132.73% | 99.13% | 115.86% |
| Normalized Diluted EPS | 3.48% | 8.93% | 27.41% | 24.96% | 22.19% |
| Average Basic Shares Outstanding | -2.96% | -2.70% | -1.86% | -1.18% | -0.95% |
| Average Diluted Shares Outstanding | -3.08% | -2.79% | -1.89% | -1.09% | -0.73% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.03% | 0.11% | -0.57% | -0.50% | -0.54% |